Daniel G. Welch, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 1,204 shares at $123.93 ($149K) on 2017-07-31, disclosed to the SEC on 2017-08-02.
Open-market sale of $149k ICPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.93 | 602 | $75K | 50.0% |
| 2 | $123.93 | 602 | $75K | 50.0% |
| Total | $123.93 avg | 1,204 | $149K | 100% |
| Filing → |
| SGEN | SELL | 2023-05-03 | $9.8M | — | Filing → |
| SGEN | SELL | 2023-04-05 | $12.5M | — | Filing → |
| SGEN | SELL | 2023-03-17 | $1.4M | — | Filing → |